Capsule Endoscopy Market Size, Growth Drivers, Future Projections, Report 2023-2028

According to IMARC Group latest report titled "Capsule Endoscopy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on capsule endoscopy market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global capsule endoscopy market size reached US$ 448.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 728.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8% during 2023-2028.

Get a Sample Copy of this Report: https://www.imarcgroup.com/capsule-endoscopy-market/requestsample

A capsule endoscopy is a non-invasive medical procedure that involves swallowing a small, pill-sized capsule containing a tiny camera. This capsule is designed to capture images of the digestive tract as it passes through the gastrointestinal system. The camera transmits high-quality images to a recording device worn by the patient, allowing healthcare professionals to examine the esophagus, stomach, and small intestine visually. This diagnostic tool is particularly useful for detecting gastrointestinal disorders such as Crohn's disease, small intestine tumours, or obscure bleeding that might not be easily identified through traditional endoscopy or imaging techniques. Capsule endoscopy offers a patient-friendly alternative to conventional procedures, providing valuable insights into the small bowel without requiring invasive measures.

Market Trends:

The global market is majorly driven by the rapid technological advancements. In line with this, the continuous improvements in camera resolution, battery life, and data transmission capabilities are positively influencing the market. As patients and healthcare professionals seek less invasive alternatives, the non-surgical and patient-friendly nature of capsule endoscopy becomes a significant driver, especially in detecting gastrointestinal disorders such as Crohn's disease, small intestine tumours, and obscure bleeding. Furthermore, the growing prevalence of gastrointestinal diseases globally contributes to the accelerating demand for advanced diagnostic tools, positioning capsule endoscopy as a valuable solution. The procedure's ability to provide detailed imaging of the small intestine, an area challenging to access with traditional endoscopy, further fuels its adoption.

Moreover, as healthcare systems prioritize early detection and prevention, capsule endoscopy proves instrumental in identifying and monitoring conditions at an earlier stage, catalyzing the market. Ageing populations and a rising awareness of gastrointestinal health also contribute to market growth. With an increasing number of elderly individuals susceptible to gastrointestinal issues, there is a heightened demand for non-invasive diagnostic procedures. Additionally, patient preference for less discomfort and reduced recovery times aligns with the convenience offered by capsule endoscopy, propelling the market. The expanding range of applications for capsule endoscopy, beyond diagnosis to therapeutic monitoring and drug delivery systems, broadens its market scope. As research and development initiatives continue to explore new functionalities and applications, the versatility of capsule endoscopy in the medical field is likely to drive sustained market growth.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/capsule-endoscopy-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Boston Scientific Corporation
• CapsoVision Inc.
• Check Cap Ltd
• Fujifilm Holdings Corporation
• IntroMedic Co. Ltd
• Jinshan Science & Technology (Group) Co. Ltd.
• Medtronic plc
• Olympus Corporation
• RF Co. Ltd.
• Shangxian Minimal Invasive Inc

Capsule Endoscopy Market Segmentation:

Our report has categorized the market based on region, product, accessory and application.

Breakup by Product:
• Small Bowel
• Esophageal
• Colon

Breakup by Accessory:
• Wireless Capsule
• Workstation and Recorder

Breakup by Application:
• OGIB
• Crohn's
• Small Intestine Tumors

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.